MARKET ACCESS & STRATEGY
HOW DO YOU QUANTIFY MARKET POTENTIAL?
From pre-clinical through phase III, more information and smarter insights increases the probability that you will be making the right decisions for future growth. How important are the various attributes of your product? What is the best target product profile (TPP) that will maximize value across patients, physicians, key opinion-leaders and payers? How will new reimbursement hurdles such as Value Frameworks affect market penetration? Innopiphany’s team experience in product market strategy, forecasting, and target product profile development is unsurpassed. We have experience with over 700 of these types of projects to date. Our clients trust us to identify, define, and achieve success in product development and launch. We can help you minimize market uncertainty.
700+ MARKET FORECASTS
1000+ MARKET OPPORTUNITY ASSESMENTS
30 COUNTRIES EXPERIENCED IN THE GLOBAL ARENA
50+ INDICATION SEQUENCING EVALUATIONS
HEALTH DATA ANALYTICS
keyboard_arrow_downHOW DO YOU MAKE DATA WORK HARDER FOR YOU?
Large patient data sets are quickly integrated and analyzed through Innopiphany’s dataset workflow. We have extensive experience in data blending and analysis of text-based, RDMS (e.g., Oracle database) and object oriented databases using Alteryx and incorporating next generation analytic and predictive platforms. Our experience building patient dashboards can save you time and provide you with real-time insights on advanced patient care for better decision-making.
We excel at formulating policy strategies for our clients in dynamic environments, supporting their mission with consistent messaging, leveraging data analytics, and ensuring voices are heard. Whether it entails working with external advocates, key opinion leaders or speaking to the current administration, we have a successful track record in helping our clients’ voices be heard.
$100 million dollars in analysis of GDP effect of various government policies
30 Countries – experience in the global arena
110+ White papers, policy analyses, speeches & publications
HOW DO YOU SUCCESSFULLY ENGAGE ICER?
Three in four companies involved in ICER assessments have chosen Innopiphany for help. Since 2015, Innopiphany has specialized in ICER Readiness with product teams and creating company ICER best practice playbooks & PROPRIETARY* predictive machine-learning application which draws from Innopiphany’s unique database to forecast a product's likelihood of a future ICER** assessment.
ICER is an independent drug pricing watchdog that publishes reports analyzing the value and estimating a price for new treatments. Innopiphany has worked on over 65 manufacturer engagements and written more than 150 formal letters. This includes not only the comment letters but also the medical and economic analysis, corporate communications reactive statements, internal Q&A, and patient advocacy work.
We help you ensure payers will fund your product or service and that doctors can use it. On average customers report a sales increase of as much as 33% due to our reimbursement and market access work. We can integrate seamlessly into your team through extensive therapeutic and product experience having performed more than 1000 studies in over 30 countries.
1000+ reimbursement, health economics studies to date.
150 products successfully secured reimbursement via HTA or payer submission.
2 Wrote the global market access plans for 2 of the top 10 global selling drugs as measured by sales.
1 First to introduce the Disease registry and Markov Model & publish on it’s methodology in Europe.
& HEALTH EQUITY
HOW DO YOU ENGAGE PATIENTS TO ENACT CHANGE?
Drive transformative change in healthcare with our expert guidance. We understand that meaningful and lasting improvements in the healthcare landscape require collaboration and engagement with patient advocates. We recognize that patient advocates bring unique insights, lived experiences, and a deep understanding of the challenges faced by individuals navigating the healthcare system. Through our comprehensive services, we help forge strategic partnerships, foster open dialogues, and facilitate productive collaborations between our clients and patient advocates. Together, we can co-create patient-centric solutions that address unmet needs, improve healthcare delivery, and drive positive change across the industry.